CYP2E1 Polymorphism and Better Outcome after Methanol Poisoning
Response to ‘ CYP2E1 Polymorphism and Better Outcome After Methanol Poisoning’
Third-Generation Beta-Adrenoceptor Antagonists in the Treatment of Hypertension and Heart Failure
Antidiabetic Agents and Endothelial Dysfunction – Beyond Glucose Control
4,4′-DMAR: Chemistry, Pharmacology and Toxicology of a New Synthetic Stimulant of Abuse
Specific Role of α2A- and α2B-, but not α2C-, Adrenoceptor Subtypes in the Inhibition of the Vasopressor Sympathetic Out-flow in Diabetic Pithed Rats
In Vitro Functional Assessment of 22 Newly Identified CYP2D6 Allelic Variants in the Chinese Population
Inclusion of Placebos and Blinding for Ascending Dose First-in-Human Studies and Other Underpowered Phase 1 Studies has not been Justified and on Balance is Not Useful
Paraesthesia after Local Anaesthetics: An Analysis of Reports to the FDA Adverse Event Reporting System
Dietary Flavonoids Added to Pharmacological Antihypertensive Therapy are Effective in Improving Blood Pressure
Adiponectin -11377C/G and +276G/T Polymorphisms affect Adiponectin Levels but do not Modify Responsiveness to Therapy in Resistant Hypertension